ConocoPhillips vs Cronos Group Inc — how do they compare? ConocoPhillips trades at $134.1 (market cap $161.21B), while Cronos Group Inc trades at $3.22 (market cap $1.18B). The key difference: ConocoPhillips is far larger — about 136.6× Cronos Group Inc's market cap, and ConocoPhillips pays a 2.5% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold ConocoPhillips for 79 Days and Cronos Group Inc for 22 Days on average.
| COP | CRON | |
|---|---|---|
Market Cap | $161.21B | $1.18B |
Volume | 6,058,403 | 968,037 |
Sector | Energy | Health |
52-Week High | $141.22 | $3.55 |
52-Week Low | $85.66 | $2.30 |
Typical Hold Time | 79 Days | 22 Days |
Enterprise Value | $176.81B | $387.62M |
Dividend Yield | 2.5% | — |
Signals from Pluang's Aura AI — not financial advice
ConocoPhillips (COP) trades at $134.10, up 3.28% today, showing strong momentum with two consecutive quarterly earnings beats. The stock exhibits bullish technical signals with moving averages supporting upward trends. Fundamentally, the company maintains solid profitability with 14.65% net income margin and reasonable valuation at 17.75 P/E ratio. Recent developments include a 20-year LNG supply agreement with Venture Global and potential asset sales in Norway and UK operations.
Outlook remains positive with 75% analyst buy ratings and $154.75 consensus price target suggesting 15% upside. Key opportunities include energy market strength and strategic LNG expansion, while risks involve oil price volatility and geopolitical exposure in Middle East operations. The company's strong cash flow generation supports shareholder returns through dividends and buybacks.
CRON trades at $3.23, down 0.31% with a bearish technical signal. Recent earnings show volatility with Q2 2026 beating expectations ($0.09 vs $0.01) but Q4 2025 missing. Revenue grew from $118M (2024) to $147M (2025), though net income turned negative at -$9M. The company maintains strong liquidity with $827M cash and no debt, highlighted in recent investor day presentations.
Outlook is mixed: analyst consensus leans Hold (60%) with cautious optimism on international expansion and margin improvements. Key risks include sustained negative cash flow (-$67M in 2025) and competitive pressures. Upside hinges on execution of growth initiatives in Canada and Europe, with profitability projections for 2026.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
ConocoPhillips is a U.S.-based independent exploration and production firm. In 2021, it produced 1.0 million barrels per day of oil and natural gas liquids and 3.2 billion cubic feet per day of natural gas, primarily from Alaska and the Lower 48 in the United States and Norway in Europe and several countries in Asia-Pacific and the Middle East. Proven reserves at year-end 2021 were 6.1 billion barrels of oil equivalent.
Read more on COP →Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →